Form D · Pharmaceuticals

Pearl Therapeutics Inc

Redwood City, CA · CIK 0001413805

Offering snapshot reported Nov 14, 2012 · SEC filing

Reported sold
$23.3M
Offering amount: $66.1M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 29, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 14, 2012Initial$23,273,192No comparison6SEC filing
Nov 14, 2012Initial$13,300,133No comparison6SEC filing
Nov 18, 2010Initial$37,453,334No comparison6SEC filing
Sep 26, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-186914

Source: Form D, filed Nov 14, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Charles Bramlage Director, Executive
Sarvajna Dwivedi Executive
Kevin Ferro Director
Michael Golden Executive
Steven Jaharis Director
Sundar Kodijalam Director
Sundar Kodiyalam Director
Thomas Koestler Director
Kathy Laporte Director
James Niedel Director
Chadwick Orevillo Executive
William Picht, Jr. Executive
Colin Reisner Executive
Howard B. Rosen Director
Nicholas J. Simon Director
James W. Young Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
200 Saginaw Drive
Redwood City, CA, 94063